Wireframe Ventures
@WireframeVC
We specialize in helping extraordinary seed-stage founders on a mission to improve the health of people and planet
Exciting milestone for Argon AI—we’ve raised a $5.5 million seed round led by @CrosslinkCap and @WireframeVC , with support from @ycombinator , @pioneer_fund , and industry operators. Grateful to our customers for their trust and our investors @ThePhilBoyer, @harsh1,…
Proud to see portco @PhytoformLabs team up with @corteva to deploy AI‑driven gene editing on corn—fine‑tuning two native genes for disease resilience without GMOs. Another milestone pushing biotech from lab to field 🌍🌽 agfundernews.com/phytoform-and-…
“Our mission isn't just to uncover nature's chemistry, it's to translate these discoveries into treatments that could change lives today.” Enveda’s founder @viswacolluru spoke with @bbc about how life’s chemistry is a critical source of new medicines in #TheNextFrontier series.
Why we are here... At Enveda, we’re unlocking the secrets of life’s chemistry and harnessing billions of years of evolution to bring #hope to those we love. We are proud to tell our story in #TheNextFrontier, a global series presented by the @Biotechnology Innovation…
On the cover… The Great Unknown: Chemistry’s Untapped Frontier in Understanding Life Behind every groundbreaking biological discovery lies a hidden chemical dance—millions of unseen reactions occurring every second. Our research published in @GENBiotechJrnl spotlights…
Looking for cracked entrepreneurial devs to join us in building the world's first "Async AI Software Engineer" DMs open :)
More than a clinical milestone – this marks real momentum for our lead asset. Our first-in-class oral therapeutic, ENV-294, cleared a major Phase I milestone with favorable safety results and it's showing potential to transform care for #atopicdermatitis patients. Read more:…
Climate resilience is a new market being built in real time. At our #SFClimateWeek2025 panel on Engineering Global Resilience, leaders from Google, Gridware, Understory & Nephila shared challenges & new tech approaches to managing climate risk 👇 wireframevc.com/community/sf-c…
🚀 We’ve been backed by leading investors behind @SpaceX, @amazon, and other world-changing companies, and now we’re adding one of the biggest names in #pharma to our list. Today, we’re excited to share that Sanofi has joined our Series C syndicate, bringing the total raise to…
The US battery storage market will 10x by 2035. Without optimization, billions get left on the table. Portco @tybaenergy is the autopilot for batteries, ensuring assets sell power at peak value—turning volatility to profit. Read about their $13.9M Series A heatmap.news/climate-tech/t…
#Asthma affects >250M people worldwide and has seen no new meaningful drug approvals in over a decade. Today, Enveda is announcing that we are expanding our first-in-class lead asset, ENV-294 in asthma, along with a world-class Asthma Advisory Board. Read more here:…
The energy industry is facing unprecedented changes — rising #electricity demand, evolving markets, and a shifting political landscape. The road ahead is full of opportunities for #energystorage, but also new challenges. We share four predictions for 2025 bit.ly/42JPunB
We’re thrilled to introduce something special today… The inaugural issue of 𝗜𝗻-𝗩𝗲𝗱𝗮, a periodic collection of our thoughts and findings at the intersection of technology, science, and humanity. We believe sharing the stories, breakthroughs, and perspectives that shape…
What if you had a platform that can simultaneously discover new targets *and* leads at scale? Just how many molecules exist in the entire plant kingdom? Read on to find out in this inaugural edition of In-Veda from @lifeschemistry
We’re thrilled to introduce something special today… The inaugural issue of 𝗜𝗻-𝗩𝗲𝗱𝗮, a periodic collection of our thoughts and findings at the intersection of technology, science, and humanity. We believe sharing the stories, breakthroughs, and perspectives that shape…
Heating & cooling buildings is the largest energy cost in real estate. Geothermal HVAC solutions from Bedrock Energy will cut costs by 50% while reducing harmful emissions. Congrats to the team on raising a $12M Series A to scale across the U.S. 🏢 axios.com/pro/climate-de…
Exciting news: @lbernicker’s has been promoted to Partner at @WireframeVC! In 3 short years, she's made significant contributions through strategic investments and unwavering support. Read more: wireframevc.com/community/lily… #VCWins #WomenInVC
The Climate Compass report—co-authored by Wireframe’s @lbernicker—highlights a new wave of climate startups making an impact, incl. portfolio co’s Xcimer, @salientpredict, @Caladan_Bio, and @gridwareinc. Read the full report here: climatecompassreport.com/report
The human & financial toll of climate disasters? 1.6B lives & $2T (per @iccwbo). We must invest in resilience: 🚀 Faster disaster response (@NearSpaceLabs) ⚡️ Grid protection (@gridwareinc) 🌦️ Smarter forecasts (@salientpredict) learn more: wireframevc.com/community/inve…
Phytoform’s AI technology CRE.AI.TIVE can redesign plant DNA to futureproof our food supply. synbiobeta.com/read/ai-meets-… Our foundation plant genomic model, detailed in a paper published today on the pre-print platform BioRxiv biorxiv.org/content/10.110… #AI
Carbon credits meet true climate impact. @absclimate’s new standard brings integrity and transparency to carbon removal. In partnership with @EvidentGlobal, they’re ensuring every credit aligns with real climate results. ✅🌎 markets.businessinsider.com/news/stocks/ab…
Another one to round out a big year at Enveda! 130 million more chances to deliver new hope to patients, the work experience of a lifetime for our employees, incredible returns to our investors, breakthrough technology to the world, and knowledge (Veda) to humanity 🚀
We’re thrilled to announce $130M in Series C funding led by @KinnevikAB and FPV, with participation from @BaillieGifford , @premjiinvest , @Lux_Capital , @trueventures , and many more new and existing partners. With this new capital, we plan to advance multiple drug candidates…